Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
34.6M
-
Shares change
-
-649K
-
Total reported value, excl. options
-
$660M
-
Value change
-
-$14.4M
-
Put/Call ratio
-
1.93
-
Number of buys
-
77
-
Number of sells
-
-54
-
Price
-
$19.07
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q2 2016
215 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2016.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.6M shares
of 106M outstanding shares and own 32.78% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.77M shares), VANGUARD GROUP INC (3.11M shares), STATE STREET CORP (3.09M shares), Point72 Asset Management, L.P. (2.75M shares), FMR LLC (1.8M shares), BlackRock Fund Advisors (1.61M shares), venBio Select Advisor LLC (1.41M shares), BlackRock Institutional Trust Company, N.A. (1.05M shares), JENNISON ASSOCIATES LLC (1.05M shares), and MORGAN STANLEY (968K shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.